Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28276
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIyngkaran, Pupalan-
dc.contributor.authorWilson, Andrew-
dc.contributor.authorWong, James-
dc.contributor.authorPrior, David-
dc.contributor.authorKaye, David-
dc.contributor.authorHare, David L-
dc.contributor.authorBergin, Peter-
dc.contributor.authorJelinem, Michael-
dc.date.accessioned2021-12-07T02:51:42Z-
dc.date.available2021-12-07T02:51:42Z-
dc.date.issued2021-
dc.identifier.citationCurrent Cardiology Reviews 2021; 17(5): e160721190003en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28276-
dc.description.abstractCongestive Heart Failure (CHF) is an emerging epidemic. Within one generation, the medical community has learned much of CHF syndromes. It has two distinct mechanisms, systolic and diastolic abnormalities, to account for the common CHF presentation. It is complex as it challenges the available health care services, resource, and funding models in providing an equitable service across the health continuum. Despite the improvement in many cardiovascular diseases, some CHF outcomes like readmissions and costs have increased. The reinvigoration of evidence- based medicine, the development of health services models of care, and standardisation of disease processes with taxonomies have also occurred within the same time span. These processes, however, need to be linked with health policy as presented in white papers. In this paper, we explore achieving optimal CHF guideline-recommended outcomes as the science approaches realworld translation.en
dc.language.isoeng
dc.subjectCongestive heart failureen
dc.subjectcost-efficacyen
dc.subjecthealth servicesen
dc.subjecthealth systems.en
dc.subjecttaxonomyen
dc.subjectwhite-papersen
dc.titlePart 1: The Wider Considerations in Translating Heart Failure Guidelines.en
dc.typeJournal Articleen
dc.identifier.journaltitleCurrent Cardiology Reviewsen
dc.identifier.affiliationHead of the Cardiology & Heart Failure Outpatient Clinics, University of Melbourne, Clinical Research Fellow at the St Vincent's Institute, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Cardiology, Safer Care Victoria, St Vincents Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Cardiology, Head of Echocardiography at Royal Melbourne Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Cardiology and Head Heart Failure, Heart Centre At The Alfred, Melbourne, Australiaen
dc.identifier.affiliationCardiologyen
dc.identifier.affiliationDirector of Heart Failure, Department of Cardiology, The Alfred, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Cardiology, St. Vincent's Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Heart Failure & Cardiac Imaging, School of Medicine, Sydney Medical School, Werribee Mercy Sub School, Werribee, Australiaen
dc.identifier.doi10.2174/1573403X16666210108104945en
dc.type.contentTexten
dc.identifier.pubmedid33423650
local.name.researcherHare, David L
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
crisitem.author.deptCardiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Dec 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.